Cell adhesion molecules: Druggable targets for modulating the connectome and brain disorders?

Neuropsychopharmacology

Volumn 39, Issue 1, 2014, Pages 235-

  Uhl, George R ^a   Drgonova, Jana ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDH13 PROTEIN; CELL ADHESION MOLECULE; CELL SURFACE PROTEIN; PTPRD PROTEIN; UNCLASSIFIED DRUG;

ADDICTION; ATTENTION DEFICIT DISORDER; AUTISM; BRAIN CIRCULUS ARTERIOSUS; BRAIN DISEASE; BRAIN SIZE; CONNECTOME; CRYSTAL STRUCTURE; DRUG TARGETING; EXTRACELLULAR MATRIX; GENE DELETION; GENE EXPRESSION; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HUMAN; INTRACELLULAR SIGNALING; NEUROMODULATION; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTLESS LEGS SYNDROME; SCHIZOPHRENIA; SMOKING CESSATION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CENTRAL NERVOUS SYSTEM DISEASES; METABOLISM; MOLECULARLY TARGETED THERAPY; PROCEDURES;

ANIMALS; CELL ADHESION MOLECULES; CENTRAL NERVOUS SYSTEM DISEASES; CONNECTOME; HUMANS; MOLECULAR TARGETED THERAPY;

EID: 84890445822     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.240     Document Type: Note

References (6)

1. Ciatto C, Bahna F, Zampieri N, VanSteenhouse HC, Katsamba PS, Ahlsen G et al (2010). T-cadherin structures reveal a novel adhesive binding mechanism. Nat Struct Mol Biol 17: 339-347
2. Ishiguro H, Liu QR, Gong JP, Hall FS, Ujike H, Morales M et al (2006). NrCAM in addiction vulnerability: Positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. Neuropsychopharmacology 31: 572-584
3. Li CY, Liu QR, Zhang PW, Li XM, Wei L, Uhl GR (2009). OKCAM: An ontology-based, humancentered knowledgebase for cell adhesion molecules. Nucleic Acids Res 37 (Database issue): D251-D260
4. Schormair B, Kemlink D, Roeske D, Eckstein G, Xiong L, Lichtner P et al (2008). PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 40: 946-948
5. Uetani N, Chagnon MJ, Kennedy TE, Iwakura Y, Tremblay ML (2006). Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta. J Neurosci 26: 5872-5880
6. Uhl GR, Drgon T, Johnson C, Li CY, Contoreggi C, Hess J et al (2008). Molecular genetics of addiction and related heritable phenotypes: Genome-wide association approaches identify 'connectivity constellation' and drug target genes with pleiotropic effects. Ann N Y Acad Sci 1141: 318-381